CNS Pharmaceuticals CNSP 深 沪
等待开盘 09-17 09:30:00 美东时间
9.14
-0.060
-0.65%
华盛通- 最 高9.22
- 今 开9.22
- 成交量 51.05万股
- 最 低 8.31
- 昨 收 9.20
- 总市值 525.18万
- 52周最高 221.94
- 市盈率 静 --
- 换手率 88.85%
- 52周最低 4.93
- 委 比 -33.33%
- 总股本 57.46万
- 历史最高 5121000.00
- 量 比 12.71
- 振 幅 9.89%
- 历史最低 8.31
- 每 手 1
- 风险率 29.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Shares of Webtoon Entertainment Inc (NASDAQ:WBTN) rose sharply in pre-market tr...
09-16 17:41
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target
Maxim Group analyst Jason McCarthy upgrades CNS Pharma (NASDAQ:CNSP) from Hold to Buy and announces $20 price target.
09-12 22:08
七夕前大降价！厄瓜多尔玫瑰零售价格降幅达30%
（来源：中国商报） 转自：中国商报 中国商报（记者 蒋永霞）“今天的好心情是漂亮的厄瓜多尔玫瑰给的。前几天随手在网上刷到129元一束的厄瓜多尔玫瑰，立刻下单...
08-28 16:35
CNS Pharmaceuticals shares are trading lower. The company reported Q2 financial results.
CNS Pharmaceuticals shares are trading lower. The company reported Q2 financial...
08-16 00:33
CNS Pharmaceuticals Q2 EPS $(6.42) Beats $(9.60) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(6.42) per share which beat the analyst consensus estimate of $(9.60) by 33.13 percent. This is a 98.09 percent increase over losses of $(336.00) per share
08-15 05:47
强强联合，安全护航 | 绿盟云原生容器安全产品与天翼云TeleDB完成深度适配
全文共816字，阅读大约需2分钟。 近期，绿盟云原生容器安全产品（以下简称：绿盟CNSP）与天翼云TeleDB，基于信创CPU和操作系统顺利完成了全面的产品适配...
08-12 17:58
从阿迪达斯、ABG到安踏，锐步为何被卖了一次又一次？
（来源：中国商报） 转自：中国商报 中国商报（记者 王怡菲）近日，有市场消息称，安踏或成为锐步（Reebok）品牌的新东家。这家曾与耐克、阿迪达斯分庭抗礼的老...
08-07 15:45
CNS Pharmaceuticals shares are trading lower after the company announced a 1-for-12 reverse split.
CNS Pharmaceuticals shares are trading lower after the company announced a 1-fo...
07-18 23:07
CNS Pharma Announces 1-For-12 Reverse Split Of Its Common Stock
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous
07-18 20:01
